Kolexia
Tempescul Adrian Hématologie
Tempescul Adrian
Hématologie
Hôpital Morvan
Brest, France
164 Activités
249 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Leucémie chronique lymphocytaire à cellules B Leucémies Leucémie lymphoïde Maladie de Hodgkin Myélome multiple Lymphome à cellules du manteau Récidive tumorale locale Lymphome malin non hodgkinien

Collaborateurs

Voir plus
Berthou Christian
Berthou Christian
Hôpital Morvan, Brest, France
Ianotto Jean-Christophe
Ianotto Jean-Christophe
Hôpital Morvan, Brest, France
Bagacean Cristina
Bagacean Cristina
Hôpital Morvan, Brest, France
Eveillard Jean-Richard
Eveillard Jean-Richard
Hôpital Morvan, Brest, France

Industries

Voir plus
A+A
256 collaboration(s)
Dernière en 2023
M3 Global Research Ltd
177 collaboration(s)
Dernière en 2023
IQVIA
146 collaboration(s)
Dernière en 2023
P\S\L Group Services
115 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial
The Lancet. Oncology   08 mars 2024
LOTIS 5: A Phase 3 Randomized Study of Loncastuximab Tesirine Combined With Rituximab Versus Immunochemotherapy in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (LOTIS-5)
Essai Clinique (ADC Therapeutics S.A.)   23 janvier 2024
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.
Haematologica   30 novembre 2023
CDKN2C Deletion on 1p32 Locus As Part of Irwazh Score, a New Risk Assessment Model for Venous Thromboembolism Occurring within 6-12 Months of Treatment Initiation in Newly Diagnosed Multiple Myeloma
65th ASH Annual Meeting Abstracts   02 novembre 2023
Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
Essai Clinique (The Lymphoma Academic Research Organisation)   25 septembre 2023
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in elderly mantle cell lymphoma patients. For the LYSA group.
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma: A Randomized Phase II Trial Evaluating Ibrutinib Plus CD20 Ab and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
Essai Clinique (The Lymphoma Academic Research Organisation)   16 mars 2023
Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study.
Hematological oncology   14 juillet 2022
Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA).
British journal of haematology   21 avril 2022
Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French Network.
Bone marrow transplantation   14 avril 2022